Abstract
We thank Drs Pinal-Fernandez and Mammen for their constructive comments on our article (1). We also thank them about their remark related to the correlations between muscle levels of ISG15 and muscle involvement. We fully agree that an accurate classification of Juvenile Idiopathic Inflammatory Myositis (JIIM), including MSA screening is of utmost importance (2). In Juvenile Dermatomyositis (JDM), it is also now demonstrated that the global "type 1 interferon (IFN-I) signature" in blood associates with disease severity, including the degree of muscle weakness (3).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
